Paper4158055
Exclusive occurrence of K chains in isolated cold haemagglutinins.
Harboe M and 4 others. Scand J Haematol, 1965. Cited by 131 papers, by iCite.
Cite this record
ConductScience Library. Exclusive occurrence of K chains in isolated cold haemagglutinins. Papers, record 4158055. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4158055
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Hemagglutination | |
| Immune Sera | |
| Immunodiffusion | |
| Immunoelectrophoresis | |
| gamma-Globulins |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41789059 | Framework-mediated binding of foreign and self-glycans by IGHV4-34 antibodies. | Front Immunol | 2026 | https://conductscience.org/library/papers/41789059 | PubMed |
| 38874820 | Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy. | Curr Oncol Rep | 2024 | https://conductscience.org/library/papers/38874820 | PubMed |
| 37168855 | The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket? | Front Immunol | 2023 | https://conductscience.org/library/papers/37168855 | PubMed |
| 37153870 | Sutimlimab for the Treatment of Cold Agglutinin Disease. | Hemasphere | 2023 | https://conductscience.org/library/papers/37153870 | PubMed |
| 33322221 | Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia. | J Clin Med | 2020 | https://conductscience.org/library/papers/33322221 | PubMed |
| 32318071 | New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. | Front Immunol | 2020 | https://conductscience.org/library/papers/32318071 | PubMed |
| 31523413 | Novel insights into the treatment of complement-mediated hemolytic anemias. | Ther Adv Hematol | 2019 | https://conductscience.org/library/papers/31523413 | PubMed |
| 31114413 | Cold agglutinin disease: current challenges and future prospects. | J Blood Med | 2019 | https://conductscience.org/library/papers/31114413 | PubMed |
| 30949369 | Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence? | Case Rep Hematol | 2019 | https://conductscience.org/library/papers/30949369 | PubMed |
| 30667771 | Antibodies without Antigenic Stimulation. | J R Coll Physicians Lond | 1968 | https://conductscience.org/library/papers/30667771 | PubMed |
| 27913484 | Cold agglutinin disease. | Hematology Am Soc Hematol Educ Program | 2016 | https://conductscience.org/library/papers/27913484 | PubMed |
| 26696798 | Role of Complement in Autoimmune Hemolytic Anemia. | Transfus Med Hemother | 2015 | https://conductscience.org/library/papers/26696798 | PubMed |
| 26696796 | New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia. | Transfus Med Hemother | 2015 | https://conductscience.org/library/papers/26696796 | PubMed |
| 25705656 | Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/25705656 | PubMed |
| 23399355 | Therapy for chronic cold agglutinin disease: perspective for further improvements. | Blood Transfus | 2013 | https://conductscience.org/library/papers/23399355 | PubMed |
| 17891600 | Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy. | Hematology | 2007 | https://conductscience.org/library/papers/17891600 | PubMed |
| 7323952 | Protein synthesis in rheumatoid synovial tissue. | Springer Semin Immunopathol | 1981 | https://conductscience.org/library/papers/7323952 | PubMed |
| 6018754 | The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8. | J Clin Invest | 1967 | https://conductscience.org/library/papers/6018754 | PubMed |
| 5924621 | Heterogeneity of cold haemagglutinins. | Immunology | 1966 | https://conductscience.org/library/papers/5924621 | PubMed |
| 5664402 | Chemical differences between individual human cold agglutinins. | Immunology | 1968 | https://conductscience.org/library/papers/5664402 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4158055
GET https://conductscience.org/api/papers/v1/4158055/cited_by?page=2